Long-term Polynovo shareholders see relief as US Medicare changes offer boon
Healthcare player Polynovo (ASX:PNV) has offered relief to long-term shareholders who may have been bemoaning 1Y returns down -30%.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NZB | Ann: NZB NTA 02-09-2025 $3.03044 | 07:59 | 0 | 14 | |||
|
|||||||
NZB | Ann: NZB NTA 01-09-2025 $3.03222 | 02/09/25 | 0 | 29 | |||
|
|||||||
NZB | Ann: NZB NTA 29-08-2025 $3.03218 | 01/09/25 | 0 | 21 | |||
|
|||||||
NZB | Ann: NZB NTA 28-08-2025 $3.03205 | 29/08/25 | 0 | 48 | |||
|
|||||||
NZB | Ann: NZB NTA 27-08-2025 $3.03788 | 28/08/25 | 0 | 28 | |||
|
|||||||
NZB | Ann: NZB NTA 26-08-2025 $3.03801 | 27/08/25 | 0 | 40 | |||
|
|||||||
NZB | Ann: NZB NTA 25-08-2025 $3.03718 | 26/08/25 | 0 | 51 | |||
|
|||||||
NZB | Ann: NZB NTA 22-08-2025 $3.03439 | 25/08/25 | 0 | 48 | |||
|
See All Discussions